We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
67 hedge funds and large institutions have $59.6M invested in CASI Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
160% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 5
44% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 16
14% more funds holding
Funds holding: 59 → 67 (+8)
4% more capital invested
Capital invested by funds: $57.2M → $59.6M (+$2.42M)
0.93% more ownership
Funds ownership: 2.27% → 3.2% (+0.93%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
67
Holders Change
+8
Holders Change %
+13.56%
% of All Funds
1.35%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
13
Increased
23
Reduced
16
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$13M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$12.4M |
| 3 |
Millennium Management
New York
|
+$1.21M |
| 4 |
Renaissance Technologies
New York
|
+$1.08M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
+$942K |
